➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Dow
AstraZeneca
Colorcon
Moodys
Boehringer Ingelheim

Last Updated: June 13, 2021

DrugPatentWatch Database Preview

Dihydroergotamine mesylate - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for dihydroergotamine mesylate and what is the scope of freedom to operate?

Dihydroergotamine mesylate is the generic ingredient in four branded drugs marketed by Bausch, Hikma Pharms, Paddock Llc, Provepharm Sas, Sagent Pharms Inc, West-ward Pharms Int, Cipla, Custopharm Inc, and Novartis, and is included in ten NDAs. Additional information is available in the individual branded drug profile pages.

There are six drug master file entries for dihydroergotamine mesylate. Nine suppliers are listed for this compound.

Drug Prices for dihydroergotamine mesylate

See drug prices for dihydroergotamine mesylate

Recent Clinical Trials for dihydroergotamine mesylate

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Xijing HospitalPhase 2/Phase 3
Satsuma Pharmaceuticals, Inc.Phase 3
Satsuma Pharmaceuticals, Inc.Phase 1

See all dihydroergotamine mesylate clinical trials

Pharmacology for dihydroergotamine mesylate
Medical Subject Heading (MeSH) Categories for dihydroergotamine mesylate

US Patents and Regulatory Information for dihydroergotamine mesylate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
West-ward Pharms Int DIHYDROERGOTAMINE MESYLATE dihydroergotamine mesylate INJECTABLE;INJECTION 040453-001 Jun 9, 2003 AP RX No No   Get Started Free   Get Started Free   Get Started Free
Novartis EMBOLEX dihydroergotamine mesylate; heparin sodium; lidocaine hydrochloride INJECTABLE;INJECTION 018885-001 Nov 30, 1984 DISCN No No   Get Started Free   Get Started Free   Get Started Free
Hikma Pharms DIHYDROERGOTAMINE MESYLATE dihydroergotamine mesylate INJECTABLE;INJECTION 206621-001 Sep 15, 2017 AP RX No No   Get Started Free   Get Started Free   Get Started Free
Cipla DIHYDROERGOTAMINE MESYLATE dihydroergotamine mesylate SPRAY, METERED;NASAL 212907-001 May 20, 2020 AB RX No No   Get Started Free   Get Started Free   Get Started Free
Bausch MIGRANAL dihydroergotamine mesylate SPRAY, METERED;NASAL 020148-001 Dec 8, 1997 AB RX Yes Yes   Get Started Free   Get Started Free   Get Started Free
Paddock Llc DIHYDROERGOTAMINE MESYLATE dihydroergotamine mesylate INJECTABLE;INJECTION 040475-001 Apr 28, 2003 AP RX No No   Get Started Free   Get Started Free   Get Started Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for dihydroergotamine mesylate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Bausch MIGRANAL dihydroergotamine mesylate SPRAY, METERED;NASAL 020148-001 Dec 8, 1997   Get Started Free   Get Started Free
Bausch MIGRANAL dihydroergotamine mesylate SPRAY, METERED;NASAL 020148-001 Dec 8, 1997   Get Started Free   Get Started Free
Bausch MIGRANAL dihydroergotamine mesylate SPRAY, METERED;NASAL 020148-001 Dec 8, 1997   Get Started Free   Get Started Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Moodys
Express Scripts
Johnson and Johnson
McKesson
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.